BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 4595319)

  • 41. [Experiences with immune BCG therapy of malignant melanoma].
    Altmeyer P; Nödl F
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V; Knopf B
    Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cell-mediated BCG-diagnosis using a multipuncture apparatus in melanoma].
    Wolf M
    Dermatol Monatsschr; 1976 Sep; 162(9):756-7. PubMed ID: 992184
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
    Dandapat MC; Mohapatra SK; Patra SK
    Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
    Henz BM; Macher E; Bröcker EB; Suciu S; Steerenberg PA; Jung E; Rümke P
    Dermatology; 1996; 193(2):105-9. PubMed ID: 8884144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumonitis with oral bcg.
    Schapira DV; McPherson TA
    N Engl J Med; 1977 Feb; 296(7):397. PubMed ID: 834203
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 49. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intralesional immunotherapy of melanoma with BCG.
    Rosenberg SA; Rapp HJ
    Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
    [No Abstract]   [Full Text] [Related]  

  • 53. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 54. Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
    Tarhini AA; Land S; Gupta A; Kirkwood JM
    Nat Clin Pract Oncol; 2005 May; 2(5):240-1. PubMed ID: 16264957
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
    Budzanowska E; Pawlicki M
    Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N; Crowther D
    Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 58. The immune response in human malignant melanoma.
    Mackie RM
    Clin Exp Dermatol; 1976 Mar; 1(1):23-8. PubMed ID: 773575
    [No Abstract]   [Full Text] [Related]  

  • 59. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S; Ziccardi M; Muzio GF; Filippi B
    Arch Maragliano Patol Clin; 1976; 32():114-21. PubMed ID: 802769
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of intra-lesional injection of tuberculin-active protein on metastatic nodules of human malignant melanoma].
    Saida T
    Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1399-414. PubMed ID: 6984865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.